4//SEC Filing
WEIL JOHN D 4
Accession 0000904314-17-000001
CIK 0000874710other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 1:35 PM ET
Size
23.9 KB
Accession
0000904314-17-000001
Insider Transaction Report
Form 4
WEIL JOHN D
Director10% Owner
Transactions
- Award
Option (right to buy)
2017-11-09+750→ 750 totalExercise: $2.22From: 2018-11-09Exp: 2027-11-09→ Common Stock (750 underlying)
Holdings
- 53,577
Common Stock
- 94,427(indirect: By Spouse)
Common Stock
- 59,101(indirect: By Trust)
Common Stock
- 7,927(indirect: Corporation)
Common Stock
- 119,792(indirect: By Trust)
Common Stock
- 1,500
Option (right to buy)
Exercise: $5.04From: 2010-11-13Exp: 2019-11-13→ Common Stock (1,500 underlying) - 1,500
Option (right to buy)
Exercise: $4.34From: 2011-11-11Exp: 2020-11-11→ Common Stock (1,500 underlying) - 1,500
Option (right to buy)
Exercise: $3.56From: 2012-11-10Exp: 2021-11-10→ Common Stock (1,500 underlying) - 1,500
Option (right to buy)
Exercise: $2.59From: 2013-11-08Exp: 2022-11-08→ Common Stock (1,500 underlying) - 1,500
Option (right to buy)
Exercise: $2.31From: 2014-11-14Exp: 2023-11-14→ Common Stock (1,500 underlying) - 1,500
Option (right to buy)
Exercise: $1.58From: 2015-11-13Exp: 2024-11-13→ Common Stock (1,500 underlying) - 1,500
Option (right to buy)
Exercise: $1.17From: 2016-11-12Exp: 2025-11-12→ Common Stock (1,500 underlying) - 1,500
Option (right to buy)
Exercise: $1.13From: 2017-11-10Exp: 2026-11-10→ Common Stock (1,500 underlying) - 2,500(indirect: By IRA)
Common Stock
- 495,039(indirect: By Partnership)
Common Stock
- 1,500
Option (right to buy)
Exercise: $4.05From: 2009-11-13Exp: 2018-11-13→ Common Stock (1,500 underlying)
Footnotes (13)
- [F1]On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 53,577 fewer shares.
- [F10]Owned by a family limited partnership of which the reporting person acts as one of several general partners. Number of shares reported includes all shares held by limited partnership. The reporting person disclaims beneficial ownership of shares held by the limited partnership in excess of the reporting person's proportionate interest as determined pursuant to Rule 16a-1(2)(ii)(B).
- [F11]Owned by a corporation controlled by the reporting person.
- [F12]Owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person disclaims any economic benefit in such shares.
- [F13]Options may not be exercised for a period of one year from the date of the grant and thereafter are exercisable in full.
- [F2]On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 2,500 fewer shares.
- [F3]On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 94,428 fewer shares.
- [F4]On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 59,102 fewer shares.
- [F5]On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 7,926 fewer shares.
- [F6]On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 119,795 fewer shares.
- [F7]On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 495,040 fewer shares.
- [F8]The reporting person disclaims any economic benefit in such shares.
- [F9]Owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee.
Documents
Issuer
ALLIED HEALTHCARE PRODUCTS INC
CIK 0000874710
Entity typeother
IncorporatedMO
Related Parties
1- filerCIK 0000904314
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 1:35 PM ET
- Size
- 23.9 KB